Connect with Us

Connect with Us

Connect with Us

Connect with Us

Portfolios Updates

Neurona Therapeutics Raises $102 Million to Fuel NRTX-1001 Phase 3 EPIC Epilepsy Trial and Advance Regenerative Cell Therapy Pipeline

4 April 2025

Share this article

Related Readings

LYFE Updates

LYFE Capital Sustainability Report 2025-2026

Portfolios Updates

ST Pharm secures over $500 million in oligonucleotide API contracts this year

Portfolios Updates

Taiwan’s Bora Pharmaceuticals Seeks US Growth Through M&A

Empowering global healthcare champions.

As an Investor

As an Investor

As a Founder

As an Applicant

newlp@lyfecapital.com

information@lyfecapital.com

hr@lyfecapital.com

Copyright © 2025 LYFE Capital. All Rights Reserved. Website Design by Level Up Digital.